Compare Edwards Lifesciences Corporation Common Stock (EW) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Robinhood Markets, Inc. — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Robinhood Markets, Inc. trades at $108.89 (market cap $98.46B). The key difference: Robinhood Markets, Inc. is the larger of the two by market cap, and Robinhood Markets, Inc. is more actively traded (18,771,023 versus 3,508,027). Which is the better fit depends on your goals.
| EW | HOOD | |
|---|---|---|
Market Cap | $49.44B | $98.46B |
Volume | 3,508,027 | 18,771,023 |
Sector | Health | Financials |
52-Week High | $95.18 | $152.46 |
52-Week Low | $72.65 | $65.16 |
Enterprise Value | $45.90B | $105.00B |
Typical Hold Time | — | 75 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Robinhood (HOOD) trades at $107.01, down 4.46% today, with a bullish technical signal and strong support at $105. The company reported robust revenue growth to $4.47B in 2025, with a net income margin of 42.01%, though valuation ratios like P/E of 48.46 are elevated. Recent news highlights expansion into 24/7 stock trading and AI-driven features, signaling innovation.
Outlook is positive with a consensus price target of $137, implying 28% upside, driven by product launches and market share gains. Risks include high valuation sensitivity and regulatory scrutiny over new offerings. Analyst sentiment is strongly bullish (77% buy ratings), but investors should monitor execution amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
